A peptide vendor audit is a structured check of a supplier's quality system, documents and batch evidence, done before you approve them and repeated on a schedule. For a UK lab the most reliable approach has four parts: assess the supplier's quality system, test every certificate of analysis (COA) against your specification, confirm batch traceability and handling, then record the decision and review it. We supply 99%+ HPLC purity research peptides with Certificates of Analysis, so the checks below are the ones we expect a careful lab to make of us.
TL;DR
- An audit is an inspection of the supplier's operation, facilities and quality system, not just a read of the product page. The US National Cancer Institute's supplier qualification programme uses this definition.
- Check the COA against your own specification, then check the delivery itself: invoice, delivery note and container condition.
- Traceability should run at least to batch number and expiry date, and storage should follow the manufacturer's recommendations.
- Document the approval, keep an approved vendor list and re-audit on a fixed cycle or when something changes.
- Peptides must be bought and used strictly for laboratory research. They are not for human or veterinary consumption.
Table of Contents
- What a vendor audit is, and what it is not
- Step 1: Decide the risk level and write your requirement
- Step 2: Qualify the vendor on paper
- Step 3: Test the certificate of analysis properly
- Step 4: Check traceability, storage and shipping
- Step 5: Record the approval
- Step 6: Monitor, re-audit and remove
- Worked example: auditing a new peptide supplier in one week
- Our view on what a vendor audit should reward
- Sourcing peptides you can audit
- FAQ
- Sources
What a vendor audit is, and what it is not
Many people searching this phrase find directories that score vendors, or templates written for clinics. Neither is what a research laboratory needs. A laboratory audit asks one question: does this supplier's way of working reliably give us the material our experiments assume we have?
The NCI's programme describes an audit as an inspection of a supplier's operation, facilities and quality system to judge whether its controls ensure a quality product (NCI Supplier Qualification Program). That wording matters for peptides. A single clean purity result tells you about one vial. An audit tells you whether the next batch is likely to look the same.
There are two practical levels:
- Document audit (desk review): you request and read the supplier's certificates, specifications, safety data and quality statements. This is enough for most routine reagents.
- On-site or remote audit: you inspect the facility, records and personnel training. This is reserved for high-risk or critical materials, such as a peptide that underpins a long study or a regulated assay.
The level is your call. EDQM's guidance on laboratory reagents, written for official medicines control laboratories, says the extent of verification should be decided by the laboratory itself, and that other laboratories may use it voluntarily (EDQM, Management of Reagents). Match the depth to what a failed batch would cost you in time, animals-free assay runs, grant money and credibility.
Step 1: Decide the risk level and write your requirement
Before you open any supplier's website, write down what you need. An audit has nothing to test against otherwise.
- Identity: the exact sequence, salt form and any modifications (acetylation, amidation, labels).
- Purity: the minimum purity and the method you accept, for example HPLC area percentage at a stated wavelength.
- Quantity and format: lyophilised mass per vial, and whether peptide content or net weight matters for your concentrations.
- Documents: COA per batch, safety data sheet, and any statement your institution requires.
- Delivery: temperature expectations, transit time, packaging.
Then rate the risk. A peptide used as a minor positive control sits low. A peptide whose purity drives quantitative results, or one that feeds work with external reporting, sits high and justifies a fuller audit.
Step 2: Qualify the vendor on paper
The NCI programme says initial approval should weigh the supplier's historical performance with similar materials, compliance with recognised quality systems such as GMP or ISO, and the availability of regulatory documentation (NCI Supplier Qualification Program). Translate that into a request list for a peptide vendor:
- Company identity: registered business name, a physical address and a named contact. A reachable, named account contact is a basic expectation in UK public-sector purchasing: the UKRI laboratory supplies framework requires a dedicated account team and a free helpline for legislative, safety and technical support.
- Safety information: the same framework requires safety data sheets where applicable, including COSHH information. COSHH is the UK regime for controlling hazardous substances at work, so your safety officer will want this on file.
- Quality system evidence: any ISO certificate should name the certifying body, the scope and the site it covers. Read the scope. A certificate for one site or activity does not automatically cover another.
- A sample COA for a peptide similar to yours, with the method, column and conditions stated.
- Labelling and compliance position: how the vendor labels research-only products, and how it handles chemical regulations. Our guides on research chemical labelling in the UK and UK REACH compliance for research buyers show what a buyer should expect to see.
For a fuller walk-through of this stage, see our supplier qualification guide for UK labs.
Red flags in the paperwork
The desk review is also where weak vendors show themselves. Treat these as reasons to stop and escalate to your supervisor or procurement office:
- No named contact, no address, or a registration you cannot match to the business.
- COAs with no batch number, no date, no method or no named testing laboratory.
- The same COA image reused across different products or batches.
- Wording that suggests the peptide is for people or animals: dosing advice, therapeutic claims, or "results" language. Research peptides are supplied for laboratory use only, and a vendor that blurs that line creates risk for your institution.
Step 3: Test the certificate of analysis properly
A COA is a claim until you check it against your requirement. EDQM separates two checks when reagents arrive. Administrative verification covers the invoice, the delivery note and container integrity. Scientific verification means matching the COA to the quality specification you requested (EDQM, Management of Reagents).
Apply both to every consignment:
| Check | What you compare | Typical failure |
|---|---|---|
| Product name and sequence | COA against your purchase order | Wrong salt form or missing modification |
| Batch number | COA against the vial label | Number on the COA does not appear on the vial |
| Purity | HPLC result against your minimum | Value stated without a chromatogram |
| Identity | Mass spectrometry result against the expected molecular weight | No identity test, only purity |
| Date and method | Test date, column, gradient, wavelength | Missing method or undated report |
| Container | Seal, vial condition, labelling | Damaged or unlabelled vial |
A purity percentage on its own does not confirm identity. Look for both an HPLC trace and a mass spectrometry result, and read the chromatogram: a single dominant peak with a stated integration is far more informative than a number typed into a template.
If the COA and your specification do not match, quarantine the vial, record the discrepancy and contact the supplier before the material reaches an experiment.

Step 4: Check traceability, storage and shipping
A batch that cannot be traced cannot be investigated when a result looks odd. EDQM states that reagent-use records should ensure traceability at least to batch number and expiry date, and that storage conditions should rest on the manufacturer's recommendations and known stability (EDQM, Management of Reagents).
For each peptide, ask the vendor, and then confirm on receipt:
- Batch records: is every vial labelled with a batch number that matches the COA?
- Packaging: are vials sealed, protected from light and moisture, and shipped in a way that suits a lyophilised product? Our note on peptide packaging standards lists what good looks like.
- Storage advice: does the vendor give clear storage conditions and stability information? Compare it with our guides to lyophilised peptide storage and peptide stability.
- Your own labelling: EDQM's reagent labelling expectations include the substance name, date of receipt, expiry date, storage conditions and, where relevant, concentration or purity. Apply them to every vial and aliquot once it is in your lab.
The audit does not stop at the vendor's door. Poor in-lab handling can undo a perfect supplier, so pair the audit with your own handling routine: see peptide handling guidelines and storage containers and freezer set-up.
Step 5: Record the approval
An approval that lives in someone's memory disappears when they leave. The NCI programme documents initial supplier approval on a dedicated form and keeps supplier status in a central database (NCI Supplier Qualification Program). A smaller lab can do the same with a short template and a shared approved vendor list.
A useful approval record has:
- Vendor name, address and contact.
- The products approved, and the risk level assigned.
- The documents reviewed, with dates and reviewer.
- Test results from the first delivery, including your own checks.
- The decision: approved, approved with conditions, or rejected, and the date of the next review.
Keep the file where your quality or procurement lead can find it. Auditors from funders, journals or institutional compliance teams ask for exactly this.
Step 6: Monitor, re-audit and remove
Qualification is not a one-off. In the NCI programme, approved suppliers are re-evaluated by on-site audit at least every three years, and qualified suppliers at least every six years (NCI Supplier Qualification Program). Those are one organisation's intervals for high-risk material, not a legal requirement for your lab, so set your own cycle by risk.
Whatever cycle you choose, add triggers that bring a review forward:
- A COA that fails your check, or a result in the lab that you suspect traces back to a batch.
- A change in the vendor's manufacturing site, testing laboratory or process.
- Repeated late deliveries or damaged packaging.
If the vendor supplies results from an external testing laboratory, track that laboratory too. Guidance on ISO/IEC 17025 subcontracting stresses periodic review of reported results and late-delivery patterns across the supply chain (QSE Academy). A vendor that repeatedly fails your criteria should come off the approved list, with the reason written down.
Worked example: auditing a new peptide supplier in one week
A UK group needs a 10 mg lot of a modified peptide for a binding assay and has no approved supplier yet. The assay depends on accurate concentration, so they rate the risk as medium to high.
- Day 1: they write the requirement: sequence, C-terminal amide, minimum HPLC purity of 98%, mass spectrometry identity, batch-specific COA.
- Day 2: they send a request list to the vendor: sample COA, safety data sheet, quality system certificates with scope, and the named account contact.
- Day 3: the desk review finds the sample COA has a chromatogram, a method and a batch number. The lab records this on the approval template.
- Days 4 to 5: the order is placed and the vial arrives. The lab checks the delivery note, the seal and the vial label, then matches the batch number to the COA and the purity and mass to the requirement.
- Day 6: the discrepancy list is empty. The vendor is approved for this product, with a review date set, and the vial is labelled and stored per the manufacturer's advice.
Nothing here needs an on-site visit. It needs a written requirement and the discipline to compare the paperwork with the vial.
Our view on what a vendor audit should reward
We build our process around the checks a laboratory makes at goods-in. A COA is only useful if it is specific to the batch in your hands, so our research peptides are supplied at 99%+ HPLC purity with Certificates of Analysis, and our quality controls and verification technology are there to support that document.
Our advice to any lab is to audit us the way you would audit anyone: ask for the paperwork, match it to the vial, and record the result. A supplier that welcomes that routine is one you can build an approved vendor list around.
We also keep the boundary clear. Everything we sell is for laboratory and scientific research only, never for human or veterinary consumption, and our labelling and documentation reflect that. You can read how we think about it in our guide to research use only peptides.
Neil
Sourcing peptides you can audit
If your audit checklist asks for high purity, batch-level documentation and a clear research-only position, that is what we supply. BioForgeUK offers precision research peptides at 99%+ HPLC purity, supported by Certificates of Analysis, stringent quality controls and a secure checkout, for scientists, institutions and laboratories.

Browse the range and request the documentation your approval file needs at BioForgeUK.
FAQ
How often should we re-audit a peptide vendor?
Set the interval by risk. The NCI programme re-audits approved suppliers on site at least every three years and qualified suppliers at least every six, which is a useful benchmark for high-risk material. Bring the review forward after a failed COA check, a change of site or process, or repeated delivery problems.
Do we need an on-site audit for every peptide vendor?
No. EDQM says the level of verification should be decided by the laboratory. A desk review plus a goods-in check against your specification suits most routine research peptides. Reserve on-site or remote audits for critical materials.
What should we check first on a certificate of analysis?
Start with the batch number and match it to the vial, then read the HPLC chromatogram and the mass spectrometry identity result against your specification. Confirm the test date and method are stated. Compare the product name and sequence with your purchase order before anything else is used.
Can a research peptide be used on people or animals?
No. Research peptides are supplied strictly for laboratory and scientific use, not for human or veterinary consumption. If a vendor gives dosing advice or therapeutic claims, treat it as a red flag in your audit and raise it with your institution's procurement or compliance lead.
Sources
- NCI Supplier Qualification Program
- EDQM, OMCL QA document: Management of Reagents
- UKRI laboratory supplies framework, Contracts Finder
- QSE Academy, ISO/IEC 17025 services procedure
